CORRECTION article

Front. Pharmacol., 28 August 2023

Sec. Experimental Pharmacology and Drug Discovery

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1271953

Corrigendum: Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect

  • 1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

  • 2. State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China

Article metrics

View details

1,2k

Views

572

Downloads

In the published article, there was an error in Figure 2 as published. The upper panels in Figures 2B, D were inadvertently misused during the final assembly of Figure 2. The corrected Figure 2 appear below.

FIGURE 2

FIGURE 2

EBI suppresses growth, migration, and invasion of SW620 cells. (A) SW620 cells were observed for morphologic changes at 12 h after EBI (10, 15, 20, 40, and 100 μg/mL) treatment. Scale bars indicate 50 μm. (B, C) The representative image (B) and quantitative analysis (C) of migrated cells after exposure to EBI (10, 15, 20, and 40 μg/mL, 24 h). Scale bars indicate 50 μm. (D, E) The representative image (D) and quantitative analysis (E) of invaded cells after exposure to EBI (10, 15, 20, and 40 μg/mL, 24 h). Scale bars indicate 50 μm. Mean ± SEM. ***p < 0.001, ****p < 0.0001 vs. EBI 0 μg/mL group (one-way ANOVA).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Erigeron breviscapus injection, Dengzhanxixin, Erigeron breviscapus (Vant.) Hand.-Mazz, colorectal cancer, necroptosis, drug resistance

Citation

Guo X, Li R, Cui J, Hu C, Yu H, Ren L, Cheng Y, Jiang J, Ding X and Wang L (2023) Corrigendum: Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect. Front. Pharmacol. 14:1271953. doi: 10.3389/fphar.2023.1271953

Received

03 August 2023

Accepted

14 August 2023

Published

28 August 2023

Volume

14 - 2023

Edited and reviewed by

Zhaohui Wang, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Updates

Copyright

*Correspondence: Jiandong Jiang, ; Xiao Ding, ; Lulu Wang,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics